Clinical significance of plasma VEGF value in ischemic stroke - research for biomarkers in ischemic stroke (REBIOS) study

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Matsuo, Ryu ^a   Ago, Tetsuro ^a   Kamouchi, Masahiro ^a   Kuroda, Junya ^a   Kuwashiro, Takahiro ^a   Hata, Jun ^b   Sugimori, Hiroshi ^a   Fukuda, Kenji ^d   Gotoh, Seiji ^b   Makihara, Noriko ^c   Fukuhara, Masayo ^b   Awano, Hideto ^e   Isomura, Tetsu ^e   Suzuki, Kazuo ^e   Yasaka, Masahiro ^c   Okada, Yasushi ^c   Kiyohara, Yutaka ^b   Kitazono, Takanari ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^d ST MARY S HOSPITAL   (Japan)

^e Molecuence Corporation   (Japan)

Author keywords

Brain infarction; Functional outcome; Modified rankin scale (mRS); National Institute of health stroke scale (NIHSS); Vascular endothelial growth factor (VEGF)

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VASCULOTROPIN;

AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HUMAN; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR;

AGED; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84875847974     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-32     Document Type: Article

References (22)

1. Fan YY, Hu WW, Dai HB, Zhang JX, Zhang LY, He P, Shen Y, Ohtsu H, Wei EQ, Chen Z. Activation of the central histaminergic system is involved in hypoxia-induced stroke tolerance in adult mice. J Cereb Blood Flow Metab 2011, 31(1):305-314. 10.1038/jcbfm.2010.94, 3049494, 20588322.
2. Lees KR, Bluhmki E, Von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, Allen K, Mau J, Meier D, Del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010, 375(9727):1695-1703. 10.1016/S0140-6736(10)60491-6, 20472172.
3. Storkebaum E, Lambrechts D, Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 2004, 26(9):943-954. 10.1002/bies.20092, 15351965.
4. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219(4587):983-985. 10.1126/science.6823562, 6823562.
5. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003, 9(6):653-660. 10.1038/nm0603-653, 12778163.
6. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003, 111(12):1843-1851. 161428, 12813020.
7. Lennmyr F, Ata KA, Funa K, Olsson Y, Terent A. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J Neuropath Exp Neur 1998, 57(9):874-882. 10.1097/00005072-199809000-00009, 9737551.
8. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N, Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000, 106(7):829-838. 10.1172/JCI9369, 517814, 11018070.
9. Zhang ZG, Zhang L, Tsang W, Soltanian-Zadeh H, Morris D, Zhang R, Goussev A, Powers C, Yeich T, Chopp M. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab 2002, 22(4):379-392.
10. Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J. Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke J Cereb Circ 2000, 31(8):1863-1870.
11. Lee SC, Lee KY, Kim YJ, Kim SH, Koh SH, Lee YJ. Serum VEGF levels in acute ischaemic strokes are correlated with long-term prognosis. Eur J Neurol 2010, 17(1):45-51. 10.1111/j.1468-1331.2009.02731.x, 19566899.
12. Kamouchi M, Ueda K, Ago T, Nitta H, Kitazono T. Relationship between asian dust and ischemic stroke: a time-stratified case-crossover study. Stroke J Cereb Circ 2012, 43(11):3085-3087.
13. Kumai Y, Kamouchi M, Hata J, Ago T, Kitayama J, Nakane H, Sugimori H, Kitazono T. Proteinuria and clinical outcomes after ischemic stroke. Neurology 2012, 78(24):1909-1915. 10.1212/WNL.0b013e318259e110, 22592359.
14. Kiyohara Y, Kubo M, Kato I, Tanizaki Y, Tanaka K, Okubo K, Nakamura H, Iida M. Ten-year prognosis of stroke and risk factors for death in a Japanese community: the Hisayama study. Stroke J Cereb Circ 2003, 34(10):2343-2347.
15. Kubo M, Hata J, Ninomiya T, Matsuda K, Yonemoto K, Nakano T, Matsushita T, Yamazaki K, Ohnishi Y, Saito S, Kitazono T, Ibayashi S, Sueishi K, Iida M, Nakamura Y, Kiyohara Y. A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat Genet 2007, 39(2):212-217. 10.1038/ng1945, 17206144.
16. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke J Cereb Circ 1993, 24(1):35-41.
17. Graves SF, Kobayashi SD, Braughton KR, Whitney AR, Sturdevant DE, Rasmussen DL, Kirpotina LN, Quinn MT, DeLeo FR. Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity. J Leukoc Biol 2012, 92(2):361-374. 10.1189/jlb.1111575, 3395418, 22581932.
18. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15(7):539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S, 9686693.
19. Zacharek A, Chen J, Cui X, Li A, Li Y, Roberts C, Feng Y, Gao Q, Chopp M. Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab 2007, 27(10):1684-1691. 10.1038/sj.jcbfm.9600475, 2796470, 17356562.
20. Xi L, Ghosh S, Wang X, Das A, Anderson FP, Kukreja RC. Hypercholesterolemia enhances tolerance to lethal systemic hypoxia in middle-aged mice: possible role of VEGF downregulation in brain. Mol Cell Biochem 2006, 291(1-2):205-211.
21. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, Risau W. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 2000, 156(3):965-976. 10.1016/S0002-9440(10)64964-4, 1876841, 10702412.
22. Zhang Z, Chopp M. Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends Cardiovasc Med 2002, 12(2):62-66. 10.1016/S1050-1738(01)00149-9, 11852252.